High and Persistent Anti-GM1 Antibody Titers Are Associated With Poor Clinical Recovery in Guillain-Barré Syndrome.

Saved in:
Bibliographic Details
Title: High and Persistent Anti-GM1 Antibody Titers Are Associated With Poor Clinical Recovery in Guillain-Barré Syndrome.
Authors: Thomma RCM; From the Department of Neurology (R.C.M.T., C.F., C.W., A.T.-G., W.R., P.A.D., B.C.J.), Erasmus MC, University Medical Center Rotterdam; Department of Immunology (R.C.M.T., D.M.C.V.-J., A.T.-G., W.R., R.H., B.C.J.), Erasmus MC, University Medical Center Rotterdam; Department of Neurology (C.F.), Gelre Hospital, Apeldoorn; Department of Neurology (C.W.), IJsselland Hospital, Capelle aan den IJssel; and Department of Hematology (D.M.C.V.-J.), Erasmus MC, University Medical Center Rotterdam, The Netherlands., Fokke C; From the Department of Neurology (R.C.M.T., C.F., C.W., A.T.-G., W.R., P.A.D., B.C.J.), Erasmus MC, University Medical Center Rotterdam; Department of Immunology (R.C.M.T., D.M.C.V.-J., A.T.-G., W.R., R.H., B.C.J.), Erasmus MC, University Medical Center Rotterdam; Department of Neurology (C.F.), Gelre Hospital, Apeldoorn; Department of Neurology (C.W.), IJsselland Hospital, Capelle aan den IJssel; and Department of Hematology (D.M.C.V.-J.), Erasmus MC, University Medical Center Rotterdam, The Netherlands., Walgaard C; From the Department of Neurology (R.C.M.T., C.F., C.W., A.T.-G., W.R., P.A.D., B.C.J.), Erasmus MC, University Medical Center Rotterdam; Department of Immunology (R.C.M.T., D.M.C.V.-J., A.T.-G., W.R., R.H., B.C.J.), Erasmus MC, University Medical Center Rotterdam; Department of Neurology (C.F.), Gelre Hospital, Apeldoorn; Department of Neurology (C.W.), IJsselland Hospital, Capelle aan den IJssel; and Department of Hematology (D.M.C.V.-J.), Erasmus MC, University Medical Center Rotterdam, The Netherlands., Vermeulen-de Jongh DMC; From the Department of Neurology (R.C.M.T., C.F., C.W., A.T.-G., W.R., P.A.D., B.C.J.), Erasmus MC, University Medical Center Rotterdam; Department of Immunology (R.C.M.T., D.M.C.V.-J., A.T.-G., W.R., R.H., B.C.J.), Erasmus MC, University Medical Center Rotterdam; Department of Neurology (C.F.), Gelre Hospital, Apeldoorn; Department of Neurology (C.W.), IJsselland Hospital, Capelle aan den IJssel; and Department of Hematology (D.M.C.V.-J.), Erasmus MC, University Medical Center Rotterdam, The Netherlands., Tio-Gillen A; From the Department of Neurology (R.C.M.T., C.F., C.W., A.T.-G., W.R., P.A.D., B.C.J.), Erasmus MC, University Medical Center Rotterdam; Department of Immunology (R.C.M.T., D.M.C.V.-J., A.T.-G., W.R., R.H., B.C.J.), Erasmus MC, University Medical Center Rotterdam; Department of Neurology (C.F.), Gelre Hospital, Apeldoorn; Department of Neurology (C.W.), IJsselland Hospital, Capelle aan den IJssel; and Department of Hematology (D.M.C.V.-J.), Erasmus MC, University Medical Center Rotterdam, The Netherlands., van Rijs W; From the Department of Neurology (R.C.M.T., C.F., C.W., A.T.-G., W.R., P.A.D., B.C.J.), Erasmus MC, University Medical Center Rotterdam; Department of Immunology (R.C.M.T., D.M.C.V.-J., A.T.-G., W.R., R.H., B.C.J.), Erasmus MC, University Medical Center Rotterdam; Department of Neurology (C.F.), Gelre Hospital, Apeldoorn; Department of Neurology (C.W.), IJsselland Hospital, Capelle aan den IJssel; and Department of Hematology (D.M.C.V.-J.), Erasmus MC, University Medical Center Rotterdam, The Netherlands., van Doorn PA; From the Department of Neurology (R.C.M.T., C.F., C.W., A.T.-G., W.R., P.A.D., B.C.J.), Erasmus MC, University Medical Center Rotterdam; Department of Immunology (R.C.M.T., D.M.C.V.-J., A.T.-G., W.R., R.H., B.C.J.), Erasmus MC, University Medical Center Rotterdam; Department of Neurology (C.F.), Gelre Hospital, Apeldoorn; Department of Neurology (C.W.), IJsselland Hospital, Capelle aan den IJssel; and Department of Hematology (D.M.C.V.-J.), Erasmus MC, University Medical Center Rotterdam, The Netherlands., Huizinga R; From the Department of Neurology (R.C.M.T., C.F., C.W., A.T.-G., W.R., P.A.D., B.C.J.), Erasmus MC, University Medical Center Rotterdam; Department of Immunology (R.C.M.T., D.M.C.V.-J., A.T.-G., W.R., R.H., B.C.J.), Erasmus MC, University Medical Center Rotterdam; Department of Neurology (C.F.), Gelre Hospital, Apeldoorn; Department of Neurology (C.W.), IJsselland Hospital, Capelle aan den IJssel; and Department of Hematology (D.M.C.V.-J.), Erasmus MC, University Medical Center Rotterdam, The Netherlands., Jacobs BC; From the Department of Neurology (R.C.M.T., C.F., C.W., A.T.-G., W.R., P.A.D., B.C.J.), Erasmus MC, University Medical Center Rotterdam; Department of Immunology (R.C.M.T., D.M.C.V.-J., A.T.-G., W.R., R.H., B.C.J.), Erasmus MC, University Medical Center Rotterdam; Department of Neurology (C.F.), Gelre Hospital, Apeldoorn; Department of Neurology (C.W.), IJsselland Hospital, Capelle aan den IJssel; and Department of Hematology (D.M.C.V.-J.), Erasmus MC, University Medical Center Rotterdam, The Netherlands. b.jacobs@erasmusmc.nl.
Source: Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2023 Apr 14; Vol. 10 (4). Date of Electronic Publication: 2023 Apr 14 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Wolters Kluwer Health/Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101636388 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 2332-7812 (Electronic) Linking ISSN: 23327812 NLM ISO Abbreviation: Neurol Neuroimmunol Neuroinflamm Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first